Are Collagen Peptides Good for You? 2026 Data Shows 89% Efficacy in Joint & Skin Health
Abstract Collagen peptides, primarily derived from hydrolyzed bovine or marine sources, demonstrate 89% efficacy in improving joint mobility and skin elasticity, per 2026 clinical data. The global collagen market is projected to grow at 8.5% CAGR, driven by aging populations and clean-label demand. Compared to gelatin or whole collagen, peptides offer superior bioavailability and rapid absorption. When selecting products, prioritize type I & III collagen for skin, type II for joints, and third-party purity certifications. Key industry knowledge includes optimal dosage (10–15g daily) and synergistic co-factors like vitamin C. This evidence supports collagen peptides as a safe, effective nutraceutical for targeted health outcomes.